Showing results (441-450 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|August 5, 2004
Preliminary evaluation in vitro of the inhibition of cell proliferation, cytotoxicity and induction of apoptosis by 1,4-bis(1-naphthyl)-2,3-dinitro-1,3-butadieneMaurizio Viale, Maria A Mariggiò, Massimo Ottone, et al.
Investigational New Drugs|August 5, 2004
Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinomaElisabeth Miot-Noirault, Jean Legault, Florent Cachin, et al.
Investigational New Drugs|August 5, 2004
Phase I trial of continuous infusion recombinant human interleukin-4 in patients with cancerNavneet S Majhail, Mohamad Hussein, Thomas E Olencki, et al.
Investigational New Drugs|August 5, 2004
A phase I and pharmacokinetic study of the nonpolyglutamatable thymidylate synthase inhibitor ZD9331 plus docetaxel in patients with advanced solid malignanciesGarry H Schwartz, Christopher B Jones, Mitchell Garrison, et al.
Investigational New Drugs|August 5, 2004
A phase I surrogate endpoint study of SU6668 in patients with solid tumorsHenry Q Xiong, Roy Herbst, Silvana C Faria, et al.
Investigational New Drugs|January 24, 2004
Pharmacokinetic drug-drug interaction of the novel anticancer agent E7070 and acenocoumarolH J G Desirée van den Bongard, Rolf W Sparidans, David J P Critchley, et al.
Investigational New Drugs|January 24, 2004
Phase I and pharmacokinetic study of fostriecin given as an intravenous bolus daily for five consecutive daysLyly H Lê, Charles Erlichman, Linda Pillon, et al.
Investigational New Drugs|January 24, 2004
Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumorsG Varuni Kondagunta, Jennifer Bacik, Lawrence Schwartz, et al.
Investigational New Drugs|January 24, 2004
A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancerMichael Jefford, Michael Michael, Mark A Rosenthal, et al.
Investigational New Drugs|May 4, 2004
Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)Valerie Israel, Scott T Tagawa, Terry Snyder, et al.
Pageof 372